CAR-modified stem cell memory T cells show greater expansion and persistence than standard CAR T cells, enabling complete ...
CAR T-cell therapy has transformed the treatment of hematologic malignancies, yet many patients do not achieve lasting ...
Stem-cell memory T (TSCM) cells are a rare subset of immune cells with the ability to self-renew, persist long term, and ...
Kidney damage is a serious complication affecting individuals with lupus, an autoimmune disease where immune B cells malfunction and produce antibodies that attack the body's own cells, tissues, and ...
Stem-cell memory T (TSCM) cells are a rare subset of immune cells with the ability to self-renew, persist long term, and ...
CAR T-cell therapy has transformed the treatment of hematologic malignancies, yet many patients do not achieve lasting benefit – often because the ...
TP53 alterations independently predicted inferior remission, EFS, and OS after CAR T-cell therapy in relapsed/refractory B-ALL.
Study in adults and children with aplastic anemia identifies parallel evolutionary pathways used by hematopoietic stem cells ...
The Brighterside of News on MSN
Study finds low-dose CAR T therapy can drive complete cancer remission
A bone marrow transplant can buy time for people with aggressive B-cell cancers. Too often, it does not buy enough. For ...
Scientists are supercharging patients' own immune cells to try to fight HIV without today's drugs. A small study is giving a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results